Cure Autism Now(CAN) Funds research in search of answers | Fall/Winter 1997 #AutisticHistory

[Note: Shared for #AutisticHistory archive purposes. This is NOT An Autistic Ally.]

Cure Autism Now(CAN) Funds research in search of answers

COSAC Outreach, Fall/Winter 1997 

by Jon Shestack 

   The Cure Autism Now (CAN) foundation was established in California almost two years ago by a group of parents, clinicians and researchers. In looking for answers for their own children and patients, they were shocked to find how little there was in the way of both existing biological treatments and the effort to find new ones — especially given the prevalence of this disease. 

   Though many in the scientific community told parents they could not hurry science and that if an answer was to be found “they” would find it, the parents of CAN felt differently. Representing fields such as business, construction and film production these parents realized that with enough determination, money and manpower they could in fact hurry science, and help to find answers sooner. To do any less for their children was unacceptable. 

   CAN’s mission is to face this challenge with a three-fold approach. 

   First and foremost, CAN funds essential pilot research. CAN has established an outstanding Scientific Advisory Board comprised of top researchers in fields such as developmental biology, neuroimaging, genetics, immunology and molecular biology. This board evaluates the criteria needed to most effectively meet our goals, reviews all applications for funding, and ensures the highest possible level of accountability. 

   CAN also works on a practical level to unite families, clinicians and researchers — communities that have long been disconnected from each other. These efforts include the dissemination of the latest in biological and treatment information, conferences which bring together families and members of the scientific and medical communities, and think tanks which bring together the top researchers in the field of autism and other highly relevant fields. This collaborative effort also facilitates research on a pragmatic level allowing researchers to link with families who can then become subjects in their studies. 

   Finally, CAN pursues a strong activism/awareness program. CAN works with national and local media, Congress and the National Institutes of Health to encourage more aggressive funding of biological research in autism. 

   Although CAN has already funded several innovative initiatives, January of 1998 will be the first official funding cycle. CAN’s intention is to maintain a balance of basic research with long-term significance as well as research with more immediate clinical implications. 


   CAN offers funding for pilot studies generally in the $5,000 – $30,000 range. The CAN Scientific Advisory Board meets twice yearly to review proposals. The next deadline for submitting grant proposals is November 1, 1997. The next meeting to review research proposals will be in January 1998. 

   * CAN will fund four $30,000 pilot studies in 1997, and more if funding becomes available. * CAN also offers four Young Investigator’s Awards per year, at $40,000 each, renewable for a second year, to encourage bright young scientists to enter the field of autism research under the mentorship of promising established researchers. * CAN sponsors Think Tanks and Consensus meetings to help chart the future course of autism research and to encourage collaboration and coordination among researchers. 

   Following are some examples of the research efforts CAN has funded so far: 

   Cost of Disease Report: Commissioned Sandy Geschwind, PhD, Public Health Epidemiologist to produce Preliminary Report – now submitted to Journal of Autism And Developmental Disorders. Preliminary estimates show cost of disease to be $13.3 billion annually, while NIH expenditure for biomedical research in autism is less than $12 per autistic person annually. This document was generated in an effort to increase spending on autism research. The report is now widely quoted and is regularly cited by the NIH. Submitted for Publication. 

   Consensus on Diagnosis: Over thirty experts in the field of pediatric neurology participated in this CAN consensus conference. Their goal was to work together to compose a basic document that can be used as a guide for pediatricians across the country who are first faced with a very young child who may be autistic. The results are expected to be published in 1998. 

   Infectious Disease: Principal Investigator (PI) – Ian Lipkin, MD, PhD, UC Irvine, Neurobiology and Molecular Genetics Depts. A study of possible viral etiology in autism. Dr. Lipkin specializes in Borna virus research and neuropsychiatric disease. This study is co-funded with NAAR. 

   Gastroenterology: PI – Richard Sandler, MD, Rush, St Luke’s Hospital, Chicago Gastroenerological dysregulation and it’s possible relevance to Autism: a prelimenary investigation and treatment study. 

   PI: Richard Sandler, MD, Rush, St Luke’s Hospital, Chicago Gut Permeability in Autism, replication of a recent study showing increased gut permeability in autistic children. 

   Metabolic Studies: PI: Salvatore DiMauro, MD, Neurologist – specialty in mitochondial disease, Columbia University, NY Dr. DiMauro and Jay Lombard, MD (CAN Clinician’s Committee), investigated possible mitochondrial dysfunction in autism, based on small sample of preliminary data. 

   PI: Ted Page, PhD, University of California, San Diego, Neurobiology Dept. Dr. Page is conducting a study of purine metabolism defects in autism, and the development of potential treatment modalities. Additional funding for this study comes from the Stallone Foundation 

   Immunologic Studies: PI: Anne Connolly, MD, Washington University, St. Louis Dr. Connolley, in conjunction with CAN Clinician Committee member, Michael Chez, MD, is investigating preliminary data indicating antibodies to the temporal lobe in autistic patients. 

   PI: Sudhir Gupta, MD, PhD, Immunologist, University of California, Irvine A double blind, randomized study of IVIG treatment in autistic patients will indicate its possible efficacy as a treatment for some autistic children. 

   Autism Genetic Resource Exchange: CAN has established the world’s first collaborative gene bank for autism. While this is not a research project itself, it is an invaluable resource that will make the DNA of hundreds of multiplex families (families with more than one member affected by autism) available to an unlimited number of scientists across the country in a timely and efficient manner. Until now, the extreme difficulties and costs associated with enrolling multiplex families, as well as the unwillingness of scientists to share their resources, has resulted in a very slow rate of progression in the field genetic research. This is unacceptable as new tools and advances in science are making progress in this area more possible than ever. CAN believes that this resource will help to bring new scientists into the field and will motive those already working in autism to move forward at a more accelerated pace. AGRE has already succeeded in promoting collaboration among three of the five major groups currently doing genetic research, and hopes to expand that number. 

   While advances like these are exciting, there is still much work to be done. 

   Leaders in the field agree that autism will yield to science — with a coordinated effort and sustained funding. Organizations like CAN are faced with overcoming an almost 40 year lapse in scientific advancement in the field of autism. During that time there was no national organization exclusively, or even actively engaged in promoting and funding biological research in autism. 

   In working toward it’s goals, CAN actively promotes and welcomes collaboration, particularly among those also dedicated to autism research. So much still needs to be done, and the more individuals and organizations willing to dedicate themselves to this important cause, the better. 

   In the past, the autism community has been weakened from within by disagreements between various groups over issues such as aversives, inclusion, diagnostics etc. But there is so much more on which we all agree — most importantly, that we must work for a better life for people with autism. If organizations like CAN, ASA, ARI, NAAR, AIA and DDR can work together there is no end to what could be accomplished.

More With Cure Autism Now

Cure Autism Now: POLITICAL ACTION ALERT | May 13, 2001

POLITICAL ACTION ALERT – Sunday, May 13, 2001 We need the immediate help of everyone in the developmentally disabled community! A group of families have recently begun an effort to get some tax relief for the more than three million families in the US who have children with developmental disabilities. The basic idea is to…

Cure Autism Now: Antibiotics for Autism | December 2000

Antibiotics for Autism Ivanhoe Broadcast News December 2000 Antibiotics for Autism Antibiotics for AutismTelevision News Service/Medical BreakthroughsIvanhoe Broadcast News, Inc. December 2000 (Ivanhoe Newswire) — According to the National Institute of Mental Health, about 1 in every 500 people has autism — a developmental disorder that affects language and social skills. For years it’s been largely…

Cure Autism Now Parent Advisory Board as of June 1996

The CAN Parent Advisory Board The CAN international parent board will monitor research efforts from around the world, circulate the latest findings among the scientific work group, and coordinate fundraising. CAN believes that it is the interaction between concerned parents and researchers in the field that will help keep motivation high and the pace of…


Something went wrong. Please refresh the page and/or try again.


Autistic people have fought the inclusion of ABA in therapy for us since before Autism Speaks, and other non-Autistic-led autism organizations, started lobbying legislation to get it covered by insurances and Medicaid. 

ABA is a myth originally sold to parents that it would keep their Autistic child out of an institution. Today, parents are told that with early intervention therapy their child will either be less Autistic or no longer Autistic by elementary school, and can be mainstreamed in typical education classes. ABA is very expensive to pay out of pocket. Essentially, Autism Speaks has justified the big price tag up front will offset the overall burden on resources for an Autistic’s lifetime. The recommendation for this therapy is 40 hours a week for children and toddlers.

The original study that showed the success rate of ABA to be at 50% has never been replicated. In fact, the study of ABA by United States Department of Defense was denounced as a failure. Not just once, but multiple times. Simply stated: ABA doesn’t workIn study after repeated study: ABA (conversion therapy) doesn’t work. 

What more recent studies do show: Autistics who experienced ABA therapy are at high risk to develop PTSD and other lifelong trauma-related conditions. Historically, the autism organizations promoting ABA as a cure or solution have silenced Autistic advocates’ opposition. ABA is also known as gay conversion therapy.

The ‘cure’ for Autistics not born yet is the prevention of birth. 

The ‘cure’ is a choice to terminate a pregnancy based on ‘autism risk.’ The cure is abortion. This is the same ‘cure’ society has for Down Syndrome. 

This is eugenics 2021. Instead of killing Autistics and disabled children in gas chambers or ‘mercy killings’ like in Aktion T4, it’ll happen at the doctor’s office, quietly, one Autistic baby at a time. Different approaches yes, but still eugenics and the extinction of an entire minority group of people.

Fact: You can’t cure Autistics from being Autistic.

Fact: You can’t recover an Autistic from being Autistic.

Fact: You can groom an Autistic to mask and hide their traits. Somewhat. … however, this comes at the expense of the Autistic child, promotes Autistic Burnout (this should not be confused with typical burnout, Autistic Burnout can kill Autistics), and places the Autistic child at high risk for PTSD and other lifelong trauma-related conditions.

[Note: Autism is NOT a disease, but a neurodevelopmental difference and disability.]

Fact: Vaccines Do Not Cause Autism.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: